- ... ALA = alpha-linolenic acid; ARA = arachidonic acid; DHA = docosahexaenoic acid; DRI = dietary reference intake; ECMO = extracorporeal membrane oxygenation; EER = estimated energy ...
- ... the Randomized Controlled Study... Article: Maternal high-dose docosahexaenoic acid supplementation and neurodevelopment at 5 Years of preterm... Infant and Newborn Development -- see more articles Reference Desk Growth Charts (For Parents) (Nemours Foundation) Also ...
- ... update posted live 19 March 2015 (ag) Revision: docosahexaenoic acid added as a treatment for PLAN 21 August 2014 (me) ... Cited Al-Maawali A, Yoon G, Feigenbaum ...
- ... Feskanich et al 2002 , Michaëlsson et al 2003 ]. Docosahexaenoic acid (DHA) DHA therapy (1,200 mg/day) showed ... AR, Willett WC, Schaefer EJ. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A ...
- ... action overlap with those of aspirin. 12 – 14 Docosahexaenoic acid (DHA) and arachidonic acid (AA) have been identified ... Suppl). 18. Carlson SE, Rhodes PG, Ferguson MG. Docosahexaenoic acid status of preterm infants at birth and following ...
- ... CL, Voigt RG. et al. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am ... A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder [ ...
- ... plasma phospholipids), were considered relevant: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), arachidonic acid (AA)/EPA, AA/DHA, and ... SL, Polozova A. et al. The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling ...
- ... Fletcher,A.E., 20080912, Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular ... AS, Robredo PF. 2013. Effects of lutein and docosahexaenoic acid supplementation on macular pigment optical density in a ...
- ... eicosapentaenoic acid (EPA, 20:5 n‐3) and docosahexaenoic acid (DHA, 22:6 n‐3), engage in multiple ... Exposure to the n‐3 polyunsaturated fatty acid docosahexaenoic acid impairs alpha 1‐adrenoceptor‐mediated contractile responses and ...
- ... known to affect cerebellar function. Therapies under investigation: Docosahexaenoic acid (DHA) supplementation (600 mg/day) may improve clinical ... open-label extension phase demonstrated the usefulness of docosahexaenoic acid (DHA) supplementation (600 mg/day) as a safe ...
68 results